Utility:
| In this study the results support that SSc-overlap syndromes should be regarded as a separate SSc subset, distinct from limited SSc (lcSSc) and diffuse cutaneous SSc (dcSSc) due to the different disease course. 3240 prospectively included patients were analyzed.10% were diagnosed as SSc-overlap syndrome and carried significantly more often ?other antibodies? (68.0%; p<0.0001), including anti-U1RNP,-PmScl, -Ro, -La, as well as anti-Jo-1 and -Ku antibodies. These patients developed musculoskeletal involvement earlier and more frequently (62.5%) than patients diagnosed as lcSSc (32.2%) or dcSSc (43.3%). The onset of lung fibrosis and heart involvement in SSc-overlap patients was significantly earlier than in patients with lcSSc and occurred later than in patients with dcSSc |